Hughes Syndrome: Antiphospholipid Syndrome
β Scribed by Hideo Wada
- Publisher
- Carden Jennings Publishing
- Year
- 2001
- Tongue
- English
- Weight
- 39 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Objective. To demonstrate the existence of antibodies that react against malondialdehyde (MDA)modified lipoprotein(a) (MDA-Lp[a]), a molecule that exhibits behavioral similarities to MDA-modified lowdensity lipoprotein (MDA-LDL), and to assess the possible relationship of these antibodies (anti-MDA-
To elucidate the specificity of anticardiolipin antibodies (aCL) from patients with the antiphospholipid syndrome (APS) to various phospholipids (PLs), DNA, and &-glycoprotein I (&-GPI). Methods. Five monoclonal aCL were established from peripheral blood lymphocytes of 3 patients with the APS. The